News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
119 Results
Type
Article (29)
Company Profile (1)
Press Release (89)
Section
Business (76)
Deals (12)
Drug Development (5)
FDA (1)
Job Trends (6)
News (78)
Policy (3)
Tag
Alliances (9)
Approvals (1)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (3)
Biotechnology (1)
Clinical research (1)
COVID-19 (3)
Diagnostics (3)
Earnings (20)
Events (10)
FDA (2)
Funding (1)
Government (2)
Guidances (1)
Healthcare (4)
Infectious disease (3)
IPO (5)
Job creations (2)
Layoffs (5)
Medical device (2)
Medtech (2)
Mergers & acquisitions (7)
NextGen: Class of 2025 (8)
Opinion (1)
People (27)
Phase I (1)
Phase II (1)
Phase III (1)
Preclinical (2)
Real estate (4)
Regulatory (2)
Research institute (1)
Series A (1)
Startups (8)
Date
Last 365 days (7)
2025 (4)
2024 (9)
2023 (10)
2022 (30)
2021 (30)
2020 (4)
2019 (10)
2018 (6)
2017 (3)
2016 (8)
2015 (5)
Location
Asia (3)
Australia (1)
California (3)
Europe (7)
Massachusetts (5)
Northern California (2)
United States (8)
119 Results for "zymergen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Ginkgo Bioworks Completes Acquisition of Zymergen
Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that Ginkgo has completed its previously announced acquisition of Zymergen.
October 19, 2022
·
4 min read
Deals
Ginkgo to Acquire Zymergen
Acquisition is expected to accelerate the development of Ginkgo’s innovative horizontal synthetic biology platform Expect integration of Zymergen’s complementary automation, software, and data science tools.
July 25, 2022
·
13 min read
Business
Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform
Zymergen Inc. (“Zymergen” or the “Company”) today announced it has expanded its agreement with Octant to further scale their next-generation platform to develop breakthrough medicines.
July 14, 2022
·
4 min read
Biotech Bay
Zymergen to Participate in the BofA Securities 2022 Healthcare Conference
Zymergen Inc. (“Zymergen” or the “Company”), today announced the company will be participating in the upcoming BofA Securities 2022 Healthcare Conference held in Las Vegas, NV.
April 29, 2022
·
1 min read
Business
Zymergen Cuts 80 More Jobs, Parts Ways with Co-Founder
In an SEC filing, Zymergen revealed it was cutting 80 more jobs and parting with Zach Serber, its co-founder and chief scientific officer.
August 26, 2022
·
2 min read
·
Tristan Manalac
Business
Zymergen Reports Preliminary First Quarter 2022 Financial Results
Biotechnology company Zymergen Inc., reported preliminary financial results for the first quarter ended March 31, 2022.
May 12, 2022
·
5 min read
Business
Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022
Zymergen Inc. (“Zymergen” or the “Company”) today announced it will report preliminary financial results for the first quarter 2022 after market close on Thursday, May 12, 2022.
April 13, 2022
·
1 min read
Business
Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the fourth quarter and full year ended December 31, 2021.
March 22, 2022
·
7 min read
Biotech Bay
Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications
Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement to provide Zymergen Z2TM polyimide powder to 3D4Makers for use in high performance 3D printing applications.
June 28, 2022
·
4 min read
Biotech Bay
Zymergen to Present at the 42nd Annual Cowen Healthcare Conference
Zymergen Inc., announced the company will be participating in the upcoming 42nd Annual Cowen Virtual Healthcare Conference.
February 28, 2022
·
1 min read
1 of 12
Next
